CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis
Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT. CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Research & Therapy 2010, 12: r14. PMID: 20102624, PMCID: PMC2875642, DOI: 10.1186/ar2915.Peer-Reviewed Original ResearchConceptsCD16 expressionOC precursorsInflammatory arthritisHealthy controlsMethodsPeripheral blood mononuclear cellsNuclear factor kappa-B ligandCD16-positive monocytesSubset of CD14Chronic inflammatory arthritisBlood mononuclear cellsHuman peripheral bloodCD16 surface expressionColony-stimulating factorPsA patientsPsoriatic arthritisBone erosionDendritic cellsPsoriasis subjectsMononuclear cellsPeripheral bloodTumor necrosisCD16Receptor activatorBone wafersArthritis